Stocktoria
PTC THERAPEUTICS, INC. PTCT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-06-20
PTC THERAPEUTICS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.7B | $806.8M | $937.8M | $698.8M | $538.6M |
| R&D expense | $455.2M | $534.5M | $666.6M | $651.5M | $540.7M |
| SG&A expense | $347.1M | $300.9M | $332.5M | $326.0M | $285.8M |
| Operating income | $866.9M | -$302.6M | -$439.5M | -$447.4M | -$374.4M |
| Income tax | $14.0M | $176,000 | -$69.5M | -$28.5M | $5.6M |
| Net income | $682.6M | -$363.3M | -$626.6M | -$559.0M | -$523.9M |
| EPS (diluted) | $7.78 | $-4.73 | $-8.37 | $-7.79 | $-7.43 |
| Operating cash flow | $711.2M | -$107.7M | -$158.4M | -$356.7M | -$251.3M |
| Free cash flow | $702.3M | -$114.2M | -$186.9M | -$388.7M | -$279.5M |
| Cash & equivalents | $984.6M | $779.7M | $594.0M | $279.8M | $189.7M |
| Inventory | $79.6M | $23.2M | $30.6M | $21.8M | $15.9M |
| Total assets | $2.9B | $1.7B | $1.9B | $1.7B | $1.9B |
| Total liabilities | $3.1B | $2.8B | $2.7B | $2.1B | $1.9B |
| Shareholders' equity | -$205.3M | -$1.1B | -$818.6M | -$347.1M | $1.4M |
Source: SEC EDGAR filings · CIK 0001070081 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.